Business Combinations - Narrative (Details)			1 Months Ended	2 Months Ended	12 Months Ended
	May 04, 2021 USD ($) $ / shares shares	May 03, 2021 USD ($) shares	Jul. 02, 2021 USD ($) business	Jul. 31, 2021 business	Dec. 31, 2023 USD ($) shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($)
Business Acquisition [Line Items]
Consideration received on transaction	$ 350,000,000
Common stock, conversion ratio		1
Common stock, shares issued (in shares) | shares					122,899,002	132,214,695
Common stock, shares outstanding (in shares) | shares	125,399,913	54,358			122,899,002	132,214,695
Gross consideration received	$ 783,000,000
Cash acquired from trust account	433,000,000						$ 433,382,000
Cash consideration paid to stockholders	368,000,000						367,870,000
Payment of transaction costs	$ 57,000,000						56,976,000
Legacy HydraFacial shares (in shares) | shares	35,501,743
Cash paid out from net working capital adjustment related to acquisitions	$ 900,000						902,000
Working capital adjustment Class A Common Stock issued (in shares) | shares	70,860
Number of acquisitions | business				4
Payment for contingent consideration liability, financing activities					$ 1,819,000	$ 0	$ 0
HTL, Wigmore, Ecomedic and Sidermica acquisitions
Business Acquisition [Line Items]
Number of acquisitions | business			4
Purchase of capped calls related to convertible senior notes			$ 25,700,000
Payment for contingent consideration liability, financing activities			$ 1,600,000
HTL, Wigmore, Ecomedic and Sidermica acquisitions | Customer relationships
Business Acquisition [Line Items]
Weighted average amortization period					5 years
HTL, Wigmore, Ecomedic and Sidermica acquisitions | Non-compete agreement
Business Acquisition [Line Items]
Weighted average amortization period					3 years
Class A Common Stock
Business Acquisition [Line Items]
Consideration received on transaction (in shares) | shares	35,000,000
Stock purchase price (in dollars per share) | $ / shares	$ 10.00
Consideration received on transaction	$ 350,000,000
Stock redeemed (in shares) | shares	2,672,690
Stock redeemed, price (in dollars per share) | $ / shares	$ 10.00
Shares redeemed	$ 26,700,000
Common stock, shares issued (in shares) | shares	125,329,053
Common stock, shares outstanding (in shares) | shares	125,329,053
Legacy HydraFacial shares (in shares) | shares	35,501,743
Class B Common Stock
Business Acquisition [Line Items]
Consideration received on transaction (in shares) | shares		11,500,000
Consideration received on transaction		$ 25,000